Dupilumab in the Treatment of Pediatric Alopecia Areata

NCT05866562 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Dupilumab
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai